Chronic hepatitis B management based on standard guidelines in community primary care and specialty clinics

Digestive Diseases and Sciences

Volumn 58, Issue 12, 2013, Pages 3626-3633

  Ku, Kevin C ^a,b   Li, Jiayi ^c   Ha, Nghi B ^d   Martin, Marina ^e   Nguyen, Vincent G ^b   Nguyen, Mindie H ^b,e  

^a TOURO UNIVERSITY NEVADA   (United States)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^c PALO ALTO MEDICAL FOUNDATION   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Asian American; Hepatitis B treatment guidelines; Hepatitis B virus; Primary care physicians

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ENTECAVIR; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PEGINTERFERON; TELBIVUDINE; TENOFOVIR; VIRUS DNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; COMMUNITY CARE; COMMUNITY HOSPITAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES;

ADULT; ANTIVIRAL AGENTS; COMMUNITY HEALTH CENTERS; FEMALE; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 84890055994     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2889-1     Document Type: Article

References (42)

1. Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology. 2007;46:1034-1040.
2. Raimondo G, Isgro G, Caccamo G, Pollicino T, Squadrito G. Is there a downgrading in the alert about the hepatitis B virus infection in Italy? Dig Liver Dis. 2007;39:257-261.
3. Centers for Disease Control and Prevention (CDC). Characteristics of persons with chronic hepatitis B-San Francisco, California, 2006. MMWR Morb Mortal Wkly Rep. 2007;446-448.
4. Block TM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene. 2003;22:5093-5107.
5. Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis - United States, 2007 MMWR Surveill Summ. 2009;1-27.
6. El-Serag HB, Mason AC. Rising Incidence of Hepatocellular Carcinoma in the United States. N Engl J Med. 1999;340:745-750.
7. Kallman JB, Arsalla A, Park V, et al. Screening for hepatitis B, C and non-alcoholic fatty liver disease: a survey of community-based physicians. Aliment Pharmacol Ther. 2009;29:1019-1024.
8. Centers for Disease Control and Prevention (CDC). Screening for chronic hepatitis B among Asian/Pacific Islander populations-New York City, 2005. MMWR Morb Mortal Wkly Rep. 2006;505-509.
9. Nguyen TT, Taylor V, Chen MS Jr, Bastani R, Maxwell AE, McPhee SJ. Hepatitis B awareness, knowledge, and screening among Asian Americans. J Cancer Educ. 2007;22:266-272.
10. Papatheodoridis GV, Manesis EK, Manolakopoulos S, et al. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection? Hepatology. 2008;48:1451-1459.
11. Upadhyaya N, Chang R, Davis C, Conti MC, Salinas-Garcia D, Tang H. Chronic hepatitis B: perceptions in Asian American communities and diagnosis and management practices among primary care physicians. Postgrad Med. 2010;122:165-175.
12. Post SE, Sodhi NK, Peng CH, Wan K, Pollack HJ. A simulation shows that early treatment of chronic hepatitis B infection can cut deaths and be cost-effective. Health Aff (Millwood). 2011;30:340-348.
13. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol. 2008;1315-1341; quiz 1286.
14. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;661-662.
15. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clin Gastroenterol Hepatol. 2004;2:87-106.
16. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol. 2006;4:936-962.
17. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2001;34:1225-1241.
18. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507-539.
19. McMahon BJ. Natural history of chronic hepatitis B. Clin Liver Dis. 2010;14:381-396.
20. Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology. 2008;47:1363-1370.
21. Lee TH, Kim WR, Benson JT, Therneau TM, Melton LJ III. Serum aminotransferase activity and mortality risk in a United States community. Hepatology. 2008;47:880-887.
22. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ. 2004;328:983.
23. Lai M, Hyatt BJ, Nasser I, Curry M, Afdhal NH. The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol. 2007;47:760-767.
24. Tong MJ, Hsu L, Chang PW, Blatt LM. Evaluation of current treatment recommendations for chronic hepatitis B: a 2011 update. J Gastroenterol Hepatol. 2011;26:829-835.
25. Kumar M, Sarin SK, Hissar S, et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology. 2008;134:1376-1384.
26. Tong MJ, Pan CQ, Hann HW, et al. The management of chronic hepatitis B in Asian Americans. Dig Dis Sci. 2011;56:3143-3162.
27. Giannini EG, Torre F, Basso M, et al. A significant proportion of patients with chronic hepatitis B who are candidates for antiviral treatment are untreated: a region-wide survey in Italy. J Clin Gastroenterol. 2009;43:1001-1007.
28. Jung CW, Tan J, Tan N, et al. Evidence for the insufficient evaluation and undertreatment of chronic hepatitis B infection in a predominantly low-income and immigrant population. J Gastroenterol Hepatol. 2010;25:369-375.
29. Ferrante JM, Winston DG, Chen PH, de la Torre AN. Family physicians' knowledge and screening of chronic hepatitis and liver cancer. Fam Med. 2008;40:345-351.
30. Peksen Y, Canbaz S, Leblebicioglu H, Sunbul M, Esen S, Sunter AT. Primary care physicians' approach to diagnosis and treatment of hepatitis B and hepatitis C patients. BMC Gastroenterol. 2004;4:3.
31. Hwang JP, Roundtree AK, Engebretson JC, Suarez-Almazor ME. Medical care of hepatitis B among Asian American populations: perspectives from three provider groups. J Gen Intern Med. 2010;25:220-227.
32. Vu LH, Gu Z, Walton J, et al. Hepatitis B knowledge, testing, and vaccination among Chinese and Vietnamese adults in Australia. Asia Pac J Public Health. 2012;24(2):374-384.
33. Ma GX, Fang CY, Shive SE, Toubbeh J, Tan Y, Siu P. Risk perceptions and barriers to Hepatitis B screening and vaccination among Vietnamese immigrants. J Immigr Minor Health. 2007;9:213-220.
34. Chang ET, Nguyen BH, So SK. Attitudes toward hepatitis B and liver cancer prevention among Chinese Americans in the San Francisco Bay Area. Calif Asian Pac J Cancer Prev. 2008;9:605-613.
35. Taylor VM, Choe JH, Yasui Y, Li L, Burke N, Jackson JC. Hepatitis B awareness, testing, and knowledge among Vietnamese American men and women. J Community Health. 2005;30:477-490.
36. Taylor VM, Talbot J, Do HH, et al. Hepatitis B knowledge and practices among Cambodian Americans Asian. Pac J Cancer Prev. 2011;12:957-961.
37. Tran TT. Understanding cultural barriers in hepatitis B virus infection. Cleve Clin J Med. 2009;76:S10-S13.
38. Bailey MB, Shiau R, Zola J, et al. San Francisco hep B free: a grassroots community coalition to prevent hepatitis B and liver cancer. J Community Health. 2011;36:538-551.
39. Mostert MC, Richardus JH, de Man RA. Referral of chronic hepatitis B patients from primary to specialist care: making a simple guideline work. J Hepatol. 2004;41:1026-1030.
40. Veldhuijzen IK, Mostert MC, Niesters HG, Richardus JH, de Man RA. Accuracy of a referral guideline for patients with chronic hepatitis B in primary care to select patients eligible for evaluation by a specialist. Gut. 2007;56:1027-1028.
41. Dev A, Nguyen JH, Munafo L, Hardie E, Iacono L. Chronic hepatitis B - a clinical audit of GP management. Aust Fam Physician. 2011;40:533-538.
42. Arnold DT, Bentham LM, Jacob RP, Lilford RJ, Girling AJ. Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort. BMC Fam Pract. 2011;12:9.